| Application no. and date | 13856357.2 (espacenet) (Federated) (European Patent Register), 20131120 | | Patent/reg. no. and date | DK/EP 2922876, 20181010 | | Publication date | 20150930 | | Priority no. and date | US 201261728649 P, 20121120 | | EP pub. no. and date |
EP 2922876 20150930 | | Effective date | | | Applicant/owner | Mederis Diabetes, LLC, 7515 Guinevere Drive
Sugar Land, Texas 77479, US | | Applicant ref. no. | V1901-021-DK | | Inventor | NESTOR, John, J., 7515 Guinevere Drive
Sugar Land, Texas, 77479, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 38/16 (2006.01) , A61P 3/10 (2006.01) , C07K 19/00 (2006.01) | | Title | FORBEDREDE PEPTIDLÆGEMIDLER TIL INSULINRESISTENS | | Int. application no. | US2013071077 | | Int. publication no. | WO2014081872 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
